Dr Keerti is an Associate Professor at the National Institute of Pharmaceutical Education and Research (NIPER) - Raebareli, India. Dr Keerti Jain has expertise in the development of novel nanomaterials for the delivery of drugs and genetic materials. She extensively worked on dendrimers for drug delivery applications with simultaneous immunostimulation and antiangiogenic activity. She also has significant experience working on nanoparticles, nanogels, nanoemulsions, emulgel, carbon nanotubes and quantum dots, etc.

Over 30 years of expertise in intensive care and sepsis research. Former Head of Critical Care, three medical specialties: anesthesiology, intensive care, nutrition, and metabolism. PhD in Rennes, 2010, on the interest of selenocompounds in the diagnosis and treatment of sepsis, a pharmaceutical approach. Funding and Principal Investigator for a Phase II multicenter randomized controlled trial (Phase II multicenter RCT) on 60 patients in sepsis. Authored two landmark review articles in Antioxidants and Redox Signaling, addressing sepsis from the perspectives of redox biochemistry, oncology, and chaos theory (2021); and describing the potential applications of selenocompounds (2022), respectively. Recognized expert in selenocompounds and their interest in early sepsis treatment and diagnosis. Collaborated with world-class researchers across Europe and China over three decades. Delivered last year 5 lectures at international biochemistry congresses.

Dr Fouad Akkad, Founder of WePhlan, UK. Dr Fouad Akkad is a Founder of WePhlan an AI-powered pharma consulting and solutions company, Fouad brings 20 years of experience in pharmaceutical commercial strategy and operational execution. His expertise spans brand strategy, marketing, launch planning, and AI applications in pharma. He has held multiple global commercial roles at Pfizer and Abbott. Fouad focuses on integrating AI into commercial strategy, launch, and marketing to help pharma organizations strengthen planning, enhance decision-making, and scale execution. He is the author of the Pharma AI Insider newsletter, and featured in Forbes for his AI expertise in Pharma industry.

Dr. Aman Shrivastava is an Associate Professor and an active member of the TNM Research & Development Cell at the Institute of Professional Studies, College of Pharmacy, Gwalior, India. He earned his PhD in Pharmaceutical Sciences from GLA University, Mathura, and is a Young Scientist Fellowship Awardee of the Government of Madhya Pradesh, India. His research focuses on neuropharmacology and drug discovery, with particular emphasis on epilepsy, drug-resistant models, and natural product-based therapeutics. Dr. Shrivastava integrates translational neuroscience, molecular pharmacology, and innovative drug delivery strategies to address unmet therapeutic challenges in neurological disorders. He has extensive experience in in-vitro and in-vivo pharmacological screening, animal models, behavioral assays, primary cell culture, histological analysis, and molecular neuroscience techniques. His broader research interests include metabolic disorders, cancer pharmacology, and CNS pathophysiology. In addition to research, he is actively involved in scientific writing, research proposal development, and academic research management, and participates in national and international collaborative research initiatives.

Mr Mohammad Imran Khan Lodh is a pharmaceutical sales and marketing professional with over 22 years of progressive experience in Pakistan’s healthcare industry. He specializes in transforming field-level insights into actionable commercial strategies that drive measurable business outcomes. He began his professional career in education as a Montessori teacher, where he developed strong communication, behavioral understanding, and audience engagement skills. Leveraging this foundation, and transitioned into the pharmaceutical sector, where he advanced through multiple roles in sales and marketing, gaining extensive expertise in market dynamics, customer engagement, and team leadership.

Dr. Sachin Shridhar Sakat is a pharmacologist, researcher, and entrepreneur with over 15 years of experience in pharmaceutical research, drug discovery, and academia. He is the Founder Director of Shribios Innovations OPC Pvt. Ltd., Pune, and has previously held leadership and academic positions at renowned research institutes and universities in India. His research focuses on pharmacology, oncology, inflammation, diabetes, natural products, and translational drug development. Dr. Sakat has authored more than 30 peer-reviewed publications, several textbooks, book chapters, and patents, and has presented his research at numerous international scientific conferences. His contributions have earned him prestigious research fellowships and international travel grants from the Government of India.

Abhijit Khompi is a Doctoral Candidate in the Doctor of Business Administration (DBA) program at Golden Gate University's Edward S. Ageno School of Business. His research extends Socio-Technical Systems theory to examine leadership effectiveness in Al-driven healthcare organizations. With extensive professional experience in healthcare operations, Al implementation, and organizational leadership, Abhijit brings a practitioner-scholar perspective to understanding how leaders jointly optimize social and technical subsystems in technology-intensive environments. His doctoral research, supervised by Dr. Arvind Gagan and Dr. Mallica Mishra, addresses the critical gap between Al's transformative potential and healthcare organizations' capacity to realize it through effective leadership. At ISPSAI France 2026, Abhijit will present findings on how ethical, adaptive, and digital leadership behaviors shape Al acceptance and organizational effectiveness in healthcare settings, contributing theoretical advancement and practical guidance for leaders navigating the intersection of humanity and technology in the Al era.

José Alberto Ayala Ortiz, M.Sc. Pharm., M.Sc. IT, is a pharmacovigilance and drug safety expert with more than 25 years of international experience spanning both regulatory authorities and the pharmaceutical industry. His career includes roles at the Danish Medicines Agency and senior positions within pharmaceutical companies, where he has led the implementation and management of pharmacovigilance IT systems, safety databases, and electronic regulatory reporting processes. As an independent consultant and pharmacovigilance auditor, José provides strategic support to pharmaceutical companies and service providers across all aspects of drug safety compliance. He serves as both EU and local Qualified Person for Pharmacovigilance (QPPV), helping organizations maintain robust pharmacovigilance systems and meet evolving regulatory requirements.

Dr. Karveer Babanrao Aghade is an Associate Professor of Pharmacology at R. J. S. College of Pharmacy, Kokamthan, Maharashtra, India. He completed his M. Pharm. in Pharmacology in 2013 and is currently pursuing his Ph.D. from Savitribai Phule Pune University (SPPU). He has over 9 years of academic teaching experience along with 3 years of pharmaceutical industry experience. His research interests include experimental pharmacology, antiurolithiatic activity, herbal drug research, wound healing, and preclinical evaluation of natural products. He has contributed to research publications in peer-reviewed and indexed journals and has presented his research at national and international scientific forums. His research work particularly focuses on the pharmacological evaluation of medicinal plants and development of evidence-based herbal therapeutic approaches. He is actively involved in postgraduate teaching, research supervision, curriculum development, and academic activities in pharmaceutical sciences.

Dr. Prashant Bhokardankar is not only a prominent personality in Ayurveda; he is an innovator transforming the landscape of conventional medicine. Holding an MD in Ayurveda with a focus on Rasshastra from the esteemed Govt. Since 2005, he has devoted his career to enhancing the pharmaceutical elements of Ayurveda at Ayurveda College Nanded, India. As an energetic Professor and Department Head at Datta Meghe ayurvedic medical College hospital and research centre Nagpur Maharashtra India, he motivates the upcoming generation of Ayurvedic professionals while also engaging in the worldwide conversation on traditional medicine. His notable career encompasses significant positions at prestigious pharmaceutical firms like Dabur and Arya Vaidya Pharmacy, where he refined his skills in the Ayurveda pharmaceutical field. Dr. Bhokardankar is an accomplished researcher, having authored many national and international publications in indexed journals. His dedication to the field goes beyond academia, having arranged numerous seminars and workshops, enthusiastically imparting the knowledge of Ayurvedic medicine. Dr. Bhokardankar, a highly sought-after speaker at international conferences in Spain, France, Italy, and Dubai, continues to connect ancient wisdom with modern science, demonstrating the significance of Ayurveda on a worldwide stage.

Aliasgar F. Shahiwala, Ph.D., is a pharmaceutical scientist with more than 25 years of experience spanning academia and the pharmaceutical industry. His research interests encompass pharmaceutics, drug delivery, pharmaceutical product development, translational research, and computational approaches in pharmaceutical sciences. He has authored more than 70 peer-reviewed research and review articles and has edited eight books addressing drug delivery, nanomedicine, pharmaceutical polymers, and artificial intelligence in drug delivery. Dr. Shahiwala has supervised more than 35 postgraduate research projects and has contributed extensively to graduate education and research capacity development. He serves as an Academic Editor for PLOS ONE and has been recognized among the Stanford–Elsevier World’s Top 2% Scientists (2021–2025). His current scholarly interests include therapeutic optimization, translational drug development, and the integration of computational approaches with pharmaceutical sciences.

Dr. Birupaksha Biswas is an Indian physician, clinical pathologist, researcher, and academic author with expertise in diagnostic pathology, critical care medicine, molecular oncology, and translational research. He completed his MBBS from the College of Medicine & Sagore Dutta Hospital, Kolkata, followed by an MD in Pathology from Burdwan Medical College, West Bengal. He has further pursued advanced certifications in Palliative Care, Diabetes Mellitus, and Chronic Kidney Disease through collaborations involving the BMJ and the Royal College of Physicians (UK), and is presently undergoing Fellowship training in Critical Care Medicine under the NHS and Health Education England. Professionally, Dr. Biswas has worked as a Clinical Pathologist, researcher, and critical care intensivist across multiple tertiary care institutions in India. His academic and research interests include oncopathology, hematopathology, forensic pathology, regenerative medicine, digital pathology, genomics, and precision diagnostics. He has authored more than seventy peer-reviewed scientific publications along with several academic books and chapters spanning pathology, oncology, hematology, and healthcare innovation.

Idoko Alexander is a prominent Nigerian biochemist and researcher known for his extensive contributions to medical biochemistry, molecular biology, and pharmacological studies. His work, widely published in established learned journals, focuses on mitigating metabolic disorders and exploring the therapeutic properties of natural medicinal plants. Currently, Idoko serves as a lecturer and researcher in the Department of Biochemistry at Federal University of Health Sciences Otukpo, Nigeria. His scholarly work has centered on medical and pharmacological biochemistry, investigating how naturally occurring bio-compounds can be used to treat or manage diseases.